Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
from NDTV News-Latest https://ift.tt/t45Kuc3
Saturday, 20 August 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment